Top

European Journal of Nuclear Medicine and Molecular Imaging

Published in:

01-06-2016 | Letter to the Editor

Imaging of differentiated thyroid carcinoma: ¹²⁴I-PET/MRI may not be superior to ¹²⁴I-PET/CT

Authors: A. Vrachimis, M. Weckesser, M. Schäfers, L. Stegger

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 6/2016

Excerpt

Dear Sir, …

Binse I, Poeppel TD, Ruhlmann M, Gomez B, Umutlu L, Bockisch A, et al. Imaging with ¹²⁴I in differentiated thyroid carcinoma: is PET/MRI superior to PET/CT? Eur J Nucl Med Mol Imaging. 2015. doi:10.1007/s00259-015-3288-y.PubMed

Delso G, Furst S, Jakoby B, Ladebeck R, Ganter C, Nekolla SG, et al. Performance measurements of the Siemens mMR integrated whole-body PET/MR scanner. J Nucl Med. 2011;52:1914–22.CrossRefPubMed

N. E. M. Association. NEMA standards publication NU 2–2012: performance measurements of positron emission tomographs. Rosslyn, VA: National Electrical Manufacturers Association; 2012.

Wiesmuller M, Quick HH, Navalpakkam B, Lell MM, Uder M, Ritt P, et al. Comparison of lesion detection and quantitation of tracer uptake between PET from a simultaneously acquiring whole-body PET/MR hybrid scanner and PET from PET/CT. Eur J Nucl Med Mol Imaging. 2013;40:12–21.CrossRefPubMed

Vrachimis A, Burg MC, Wenning C, Allkemper T, Weckesser M, Schafers M, et al. F]FDG PET/CT outperforms [F]FDG PET/MRI in differentiated thyroid cancer. Eur J Nucl Med Mol Imaging. 2016;43:212–20.

Blodgett TM, Mehta AS, Mehta AS, Laymon CM, Carney J, Townsend DW. PET/CT artifacts. Clin Imaging. 2011;35:49–63.CrossRefPubMedPubMedCentral

Bockisch A, Beyer T, Antoch G, Freudenberg LS, Kuhl H, Debatin JF, et al. Positron emission tomography/computed tomography—imaging protocols, artifacts, and pitfalls. Mol Imaging Biol. 2004;6:188–99.CrossRefPubMed

Title: Imaging of differentiated thyroid carcinoma: 124I-PET/MRI may not be superior to 124I-PET/CT
Authors: A. Vrachimis
M. Weckesser
M. Schäfers
L. Stegger
Publication date: 01-06-2016
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Nuclear Medicine and Molecular Imaging / Issue 6/2016
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-016-3318-4

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Imaging of differentiated thyroid carcinoma: ¹²⁴I-PET/MRI may not be superior to ¹²⁴I-PET/CT

Excerpt

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 6/2016

Mauro Papotti and Wouter W. De Herder (ed): Neuroendocrine Tumors: A Multidisciplinary Approach

Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment

Current status of PET imaging in Huntington’s disease

Rudy A.J.O. Dierckx, Andreas Otte, Erik F.J. de Vries, Aren van Waarde (eds); guest editor Klaus L. Leenders: PET and SPECT in Neurology

18F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma

[123]FP-CIT SPECT scans initially rated as normal became abnormal over time in patients with probable dementia with Lewy bodies